Our research interests focus on microbial pathogenesis, particularly on the identification and characterization of bacterial virulence factors and putative vaccine antigens for the gram-negative human pathogens: Moraxella catarrhalis and Acinetobacter baumannii.
I. One major area of focus involves the gram-negative human pathogen Moraxella catarrhalis. This bacterium predominantly causes middle ear infections and sinusitis in infants and children, and lower respiratory tract infections in adults. This organism is the third leading cause of otitis media and it is estimated that approximately 50% of children will become colonized by this bacterium in the first six months of life.
M. catarrhalis-related projects ongoing in the lab: A. One prominent bacterial surface component implicated as a potential virulence factor is the lipooligosaccharide (LOS) molecule. Structural studies show that M. catarrhalis LOS is similar to the LOS of other Gram-negative human mucosal pathogens. Currently there is interest in defining the role of LOS in pathogenesis and in determining the assembly and expression of this major surface glycolipid. The focus of this work is to perform a comprehensive analysis of the genetics and biology of M. catarrhalis LOS.
B. We have now demonstrated that M. catarrhalis express peritrichious type-IV pili. Our studies indicate pilus production by this bacterium is essential for DNA uptake by natural transformation and undergoes iron-responsive regulation. Additional studies will focus on elucidating the prevalence and role of type IV pili in the pathogenesis and host response of M. catarrhalis infections. We have also entered into a collaborative study using a Chinchilla colonization model in order to correlate our in vitro studies with a relevant in vivo biologic system.
C. In addition, we are also attempting to identify specific bacterial factors involved in attachment to host tissues. M. catarrhalis often colonizes the mucosal surfaces in the nasopharynx of young children. There is a strong correlation between colonization and subsequent development of otitis media. We have recently identified a two-partner secretion (TPS) locus in M. catarrhalis termed MCH (M. catarrhalis hemagglutinin-like proteins). The MCH locus consists of three open reading frames: mchA1 and mchA2 encode homologues to the filamentous hemagglutinin of Bordetella pertussis, mchB encodes the TPS transporter. We are currently characterizing this region and are investigating the function of the M. catarrhalis TPS locus.
II. Acinetobacter baumannii, a Gram-negative pathogen, causes nosocomial infections in susceptible populations. This organism has the ability to persist for extended periods on abiotic surfaces suggesting that these bacteria form biofilms. Recently, the military has seen an increased prevalence of multi-drug resistant Acinetobacter-infections in wounded soldiers returning from Iraq and Afghanistan increasing interest in studying this under-characterized pathogen.
A. baumannii-related projects ongoing in the lab: A. The biosynthesis and expression of the lipopolysaccharide (LPS) molecule of A. baumannii is a new research focus of our laboratory. LPS is a common constituent of the outer membrane of Gram-negative bacteria and studies are underway to define the role of LPS in the pathogenesis in A. baumannii infections. Studies of defined mutants that can no longer express full-length LPS molecules will yield important insights into the virulence of this opportunistic pathogen.
B. Nosocomial A. baumannii infections have been linked to the fact that A. baumannii colonizes hospital equipment and the organism is able to resist physical and chemical disinfection by forming biofilms. One of the bacterial factors that have been shown to play a role in abiotic surface attachment, persistence and virulence is the polysaccharide poly-N-acetylated glucosamine (PGA), a large extracellular polysaccharide. We have identified a PGA-encoding locus in A. baumannii that shares homology with the previously described pga locus of E. coli, A. pleuropneumoniae, and A. actinomycetemcomitans and the homologous PNAG/PIA-encoding ica locus in S. aureus and S. epidermidis. We are interested in investigating the functional role of the PGA expressed by A. baumannii.
C. We have identified an approximately 26-kb open reading frame in the A. baumannii chromosome that encodes a large outer membrane protein homologous the biofilm-associated protein (Bap) of Staphylococcus aureus. We have produced monoclonal and polyclonal antibodies to the A. baumannii Bap-homologue and generated a transposon mutant defective in Bap expression. Our analyses indicate this protein is expressed on the bacterial surface and is conserved among clinical isolates. Additional studies will focus on the contribution of this molecule to biofilm formation and adherence of A. baumannii to abiotic surfaces.
Adjunct Assistant Professor, Medicial Technology, SUNY@Buffalo (1994-present)
Associate Professor, SUNY@Buffalo (1996–2001)
Research Assistant Professor, SUNY@Buffalo (1987–1999)
Adjunct Assistant Professor, SUNY@Buffalo (1992–1996)
Instructor, SUNY@Buffalo (1985–1987)
Post Doctoral Fellow, Division of Infectious Diseases, SUNY@Buffalo (1983–1985)
Research Expertise:
Antibody development: Development of monoclonal and polyclonal anitbodies to biothreat organisms.
Microbial pathogenesis: Gram-negative microbial pathogenesis.
Identification of colonization and virulence factors.
Identification and characterization of vaccine antigens.
Identification and characterization of biofilm associated factors
Grants and Sponsored Research:
October 2012–September 2014 Analysis of Novel Acinetobacter baumannii Adhesions NIAID Role: Principal Investigator $435,875
November 2007–December 2012 Genetics & Biology of M. catarrhalis LOS in Otitis Media NIDCD Role: Principal Investigator $1,846,053
September 2002–September 2007 Genetics & Biology of M. catarrhalis LOS in Otitis Media NIDCD Role: Principal Investigator $1,725,060
November 2002–November 2005 Comprehensive Analysis of Virulence Factors and Potential Vaccine Antigens of Haemophilus ducreyi. The John R. Oishei Foundation Role: Principal Investigator $300,000
August 2001–July 2005 Analysis of Moraxella catarrhalis LOS: Role in Immunity National Institute of Allergy and Infectious Diseases Role: Principal Investigator $851,269
February 2000–January 2005 Analysis of M. catarrhalis receptors as Vaccine Antigens National Institute of Allergy and Infectious Diseases Role: Principal Investigator $906,722
June 2002–May 2004 Capture, Isolation and Identification of Biologic Agents New York State Center for Applied Technology Role: Principal Investigator $428,000
June 2001–May 2002 Development of Monoclonal Antibodies University Service Account Role: Principal Investigator $59,108
June 1997–May 2002 Structure of Haemophilus ducreyi LOS: Role in Adherence/Invasion National Institute of Allergy and Infectious Diseases Role: Principal Investigator $806,769
PCR modification USA patent No. 5,871,906 titled; Method for the Detection of Amplified Nucleic Acid Products and Related Diagnostic Assays, 1999. (1999)
Moraxella catarrhalis a vaccine antigen. USA patent No. 6,004,562 (1999)
Concentrator/Detector USA patent No. 4,859,421 titled; Disposable Antigen Concentrator and Detector and Methods for Using Same. (1989)
Luke NR, Allen S, Gibson BW, Campagnari AA. Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant.. Infect Immun. 2003; 71(11).
Furano K, Campagnari AA. Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera.. Infect Immun. 2003; 71(4).
Schilling B, Gibson BW, Filiatrault M, Campagnari AA. Characterization of lipooligosaccharides from Haemophilus ducreyi containing polylactosamine repeats.. J Am Soc Mass Spectrom. 2002; 13(6).
Tullius MV, Phillips NJ, Scheffler NK, Samuels NM, Munson Jr RS, Hansen EJ, Stevens-Riley M, Campagnari AA, Gibson BW. The lbgAB gene cluster of Haemophilus ducreyi encodes a beta-1,4-galactosyltransferase and an alpha-1,6-DD-heptosyltransferase involved in lipooligosaccharide biosynthesis.. Infect Immun. 2002; 70(6).
Luke NR, Karalus RJ, Campagnari AA. Inactivation of the Moraxella catarrhalis Superoxide Dismutase SodA Induces Constitutive Expression of Iron-Repressible Outer Membrane Proteins.. Infect Immun. 2002; 70(4).
Filiatrault MJ, Munson RS, Anthony Campagnari. Genetic Analysis of a Pyocin-Resistant Lipooligosaccharide (LOS) Mutant of Haemophilus ducreyi: Restoration of Full-Length LOS Restores Pyocin Sensitivity.. J Bacteriol. 2001; 183(19).
Young RS, Filiatrault MJ, Fortney KR, Hood AF, Katz BP, Munson RS, Anthony Campagnari, Spinola SM. Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans.. Infect Immun. 2001; 69(6).
Zaleski A, Scheffler NK, Densen P, Lee FK, Anthony Campagnari, Gibson BW, Apicella MA. Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum.. Infect Immun. 2000; 68(9).
Filiatrault MJ, Gibson BW, Schilling B, Sun S, Munson RS, Campagnari AA. Construction and characterization of Haemophilus ducreyi lipooligosaccharide (LOS) mutants defective in expression of heptosyltransferase III and beta1,4-glucosyltransferase: identification of LOS glycoforms containing lactosamine repeats.. Infect Immun. 2000; 68(6).
Yu H, Raymonda JW, McMahon TM, Anthony Campagnari. Detection of biological threat agents by immunomagnetic microsphere-based solid phase fluorogenic- and electro-chemiluminescence.. Biosens Bioelectron. 2000; 14(10-11).
Young RS, Fortney K, Haley JC, Hood AF, Anthony Campagnari, Wang J, Bozue JA, Munson RS, Spinola SM. Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers.. Infect Immun. 1999; 67(12).
Luke NR, Anthony Campagnari. Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors.. Infect Immun. 1999; 67(11).
Luke NR, Thomas Russo, Luther N, Anthony Campagnari. Use of an isogenic mutant constructed in Moraxella catarrhalis To identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6.. Infect Immun. 1999; 67(2).
Inzana TJ, Hensley J, McQuiston J, Alan Lesse, Anthony Campagnari, Boyle SM, Apicella MA. Phase variation and conservation of lipooligosaccharide epitopes in Haemophilus somnus.. Infect Immun. 1997; 65(11).
Gibson BW, Anthony Campagnari, Melaugh W, Phillips NJ, Apicella MA, Grass S, Wang J, Palmer KL, Munson RS. Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis.. J Bacteriol. 1997; 179(16).
Hiltke TJ, Anthony Campagnari, Spinola SM. Characterization of a novel lipoprotein expressed by Haemophilus ducreyi.. Infect Immun. 1996; 64(12).
Anthony Campagnari, Ducey TF, Rebmann CA. Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin.. Infect Immun. 1996; 64(9).
Spinola SM, Orazi A, Arno JN, Fortney K, Kotylo P, Chen CY, Anthony Campagnari, Hood AF. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection.. J Infect Dis. 1996; 173(2).
Melaugh W, Anthony Campagnari, Gibson BW. The lipooligosaccharides of Haemophilus ducreyi are highly sialylated.. J Bacteriol. 1996; 178(2).
Thomas Russo, Sharma G, Brown CR, Anthony Campagnari. Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo.. Infect Immun. 1995; 63(4).
Melaugh W, Phillips NJ, Anthony Campagnari, Tullius MV, Gibson BW. Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms.. Biochemistry. 1994; 33(44).
Anthony Campagnari, Shanks KL, Dyer DW. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production.. Infect Immun. 1994; 62(11).
Westerink MA, Anthony Campagnari, Giardina P, Apicella MA. Antiidiotype antibodies as surrogates for polysaccharide vaccines.. Ann N Y Acad Sci. 1994; 730.
Anthony Campagnari, Karalus R, Apicella M, Melaugh W, Alan Lesse, Gibson BW. Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis.. Infect Immun. 1994; 62(6).
Spinola SM, Linda Wild, Apicella MA, Gaspari AA, Anthony Campagnari. Experimental human infection with Haemophilus ducreyi.. J Infect Dis. 1994; 169(5).
Brentjens RJ, Spinola SM, Anthony Campagnari. Haemophilus ducreyi adheres to human keratinocytes.. Microb Pathog. 1994; 16(3).
Gibson BW, Melaugh W, Phillips NJ, Apicella MA, Anthony Campagnari, Griffiss JM. Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry.. J Bacteriol. 1993; 175(9).
Melaugh W, Phillips NJ, Anthony Campagnari, Karalus R, Gibson BW. Partial characterization of the major lipooligosaccharide from a strain of Haemophilus ducreyi, the causative agent of chancroid, a genital ulcer disease.. J Biol Chem. 1992; 267(19).
Sarwar J, Anthony Campagnari, Kirkham C, Murphy TF. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis.. Infect Immun. 1992; 60(3).
Anthony Campagnari, Linda Wild, Griffiths GE, Karalus RJ, Wirth MA, Spinola SM. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi.. Infect Immun. 1991; 59(8).
Haase EM, Anthony Campagnari, Sarwar J, Shero M, Wirth M, Cumming CU, Murphy TF. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae.. Infect Immun. 1991; 59(4).
Westerink MA, Giardina PC, Anthony Campagnari, Apicella MA. The thymus-dependent nature of the murine antibody response to a monoclonal anti-idiotypic antibody to the Neisseria meningitidis serogroup C capsular polysaccharide.. Microb Pathog. 1990; 8(6).
Spinola SM, Kwaik YA, Alan Lesse, Anthony Campagnari, Apicella MA. Cloning and expression in Escherichia coli of a Haemophilus influenzae type b lipooligosaccharide synthesis gene(s) that encodes a 2-keto-3-deoxyoctulosonic acid epitope.. Infect Immun. 1990; 58(6).
Anthony Campagnari, Spinola SM, Alan Lesse, Kwaik YA, Mandrell RE, Apicella MA. Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens.. Microb Pathog. 1990; 8(5).
Alan Lesse, Anthony Campagnari, Bittner WE, Apicella MA. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis.. J Immunol Methods. 1990; 126(1).
Fukatsu A, Yuzawa Y, Olson L, Miller J, Milgrom M, Zamlauski-Tucker MJ, Van Liew JB, Anthony Campagnari, Niesen N, Patel J. Interaction of antibodies with human glomerular epithelial cells.. Lab Invest. 1989; 61(4).
Murphy TF, Anthony Campagnari, Nelson MB, Apicella MA. Somatic antigens of Haemophilus influenzae as vaccine components.. Pediatr Infect Dis J. 1989; 8(1 Sup).
Westerink MA, Anthony Campagnari, Nelson MB, Murphy TF, Apicella MA. New concepts in vaccines for mucosal non-enteric human bacterial pathogens.. Adv Exp Med Biol. 1989; 251.
Westerink MA, Anthony Campagnari, Wirth MA, Apicella MA. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C.. Infect Immun. 1988; 56(5).
Murphy TF, Bernstein JM, Dryja DM, Anthony Campagnari, Apicella MA. Outer membrane protein and lipooligosaccharide analysis of paired nasopharyngeal and middle ear isolates in otitis media due to nontypable Haemophilus influenzae: pathogenetic and epidemiological observations.. J Infect Dis. 1987; 156(5).
Murphy TF, Bartos LC, Anthony Campagnari, Nelson MB, Apicella MA. Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae.. Infect Immun. 1986; 54(3).
Harvey, S., Douglass, H.O., Holyoke, E.D. and Goldrosen, M.H.. Localization of an acidic protein isolated from the effusion fluid of patients with pancreatic cancer.. Tumor Diagnostik and Therapie.. 1986; 7.
Apicella MA, Dudas KC, Anthony Campagnari, Rice P, Joseph Mylotte, Murphy TF. Antigenic heterogeneity of lipid A of Haemophilus influenzae.. Infect Immun. 1985; 50(1).
Harvey, S., Douglass, H.O., Holyoke, E.D. and Goldrosen, M.H.. Detection, isolation and biochemical characterization of an acidic protein from the effusion fluid of patients with pancreatic cancer.. Tumor Diagnostik and Therapie.. 1985; 6.
Goldrosen MH, Anthony Campagnari, Howell JH, Harvey S, Jenkins D, Berjian R, Harold Douglass. Immunodiagnosis of pancreatic cancer.. Prog Clin Biol Res. 1983; 133.
"Potential Vaccine Antigens for the Prevention of Moraxella catarrhalis Induced Otitis Media." Otitis Media: New Approaches for Analysis, Treatment and Prevention, NIH, NICDCD (2000)
"Moraxella catarrhalis Lipooligosaccharides; Unique Glycolipids" Departmental Seminar, Ohio State University, Department of Molecular Microbiology, Immunology and Bacteriology (1999)
"Iron-regulated Protein Expression by Moraxella catarrhalis may be Important for Sensitivity to Human Complement." Research Exchange Series, SUNY@Buffalo, Center for Advanced Molecular Biology and Immunology (1997)
"Potential Cell Surface Receptors for Haemophilus ducreyi LOS Expressed on Human Keratinocytes" Departmental Seminar, University of California at San Francisco, Pharmaceutical Chemistry (1997)
"Iron-repressible proteins expressed during infections caused by Moraxella (Branhamella) catarrhalis" Fall Conference Microbial Pathogenesis, SUNY@Buffalo, Microbial Pathogenesis Graduate Group (1996)
"The immune response to Iron-regulated proteins expressed during otitis media caused by Moraxella catarrhalis" Departmental Seminar, Children’s Hospital of Buffalo, Department of Pediatric Infectious Diseases (1996)
"The immune response to Iron-regulated proteins expressed during otitis media caused by Moraxella catarrhalis." Seminar Series, Children’s Hospital of Buffalo, Department of Pediatric Infectious Diseases (1996)
"The major lipooligosaccharide (LOS) structure conserved on the surface of different Haemophilus ducreyi strains, binds to proteins expressed by human keratinocytes in vitro." American Society for Microbiology, 95th general meeting., American Society for Microbiology, Microbial Pathogenesis (1995)
"The role of the Lipooligosaccharides in Haemophilus ducreyi adherence and invasion of human cells" Departmental Seminar, SUNY@Buffalo, Microbiology (1995)
"A Tn916 Lipooligosaccharide (LOS) Mutant of Haemophilus ducreyi Shows a Decreased Ability to Adhere to and Invade Human Keratinocytes." 94th General Meeting, American Society for Microbiology, Microbial Pathogenesis
"Development and Current Uses for Monoclonal Antibodies." Current Trends in Clinical Laboratory Medicine, SUNY at Buffalo, Department of Medical Technology
Microbiology and Immunology, School of Medicine & Biomedical Sciences Graduate Affairs; Director (2000–2002)
Microbiology and Immunology, School of Medicine & Biomedical Sciences Graduate Affairs; Member (1998–2000)
Journal of Endotoxin Research.; Ad hoc reviewer for the Journal of Endotoxin Research.; Ad Hoc Reviewer (2001)
Microbial Pathogenesis Graduate Group.; Director of the Microbial Pathogenesis Graduate Group.; Director (2000)
Infection and Immunity.; Editorial board of Infection and Immunity.; Editorial Board Member (2000)
Director of Admissions and Recruiting MSTP.; Director of Admissions and Recruiting Medical Scientist Training Program.; Director (2000–2001)
Director of Admissions and Recruiting.; Director of Admissions and Recruiting Interdisciplinary Graduate Program in the Biomedical Sciences.; Director (2000)
Director of Graduate Studies.; Director of the graduate program, Department of Microbiology.; Director (2000–2002)
Faculty Search Committee.; Member of the Immunology Faculty Search Committee, Department of Microbiology.; Member (2000)
Preliminary Examination.; Chairman of the Preliminary Examination Committee Department of Microbiology.; Ad Hoc Reviewer (2000)
Masters Program.; Director of the masters program, Department of Microbiology.; Director (1999–2000)
Director of Recruiting IGPBS; Director of Recruiting Interdisciplinary Graduate Program in the Biomedical Sciences.; Director (1999–2000)
Curriculum review.; Member of a special ad hoc subcommittee reviewing BMS 501/502 for the Interdisciplinary Graduate Program.; Department Representative (1998)
Institutional Animal Care and Use Committee; Associate Chair of the Institutional Animal Care and Use Committee (IACUC).; Ad Hoc Reviewer (1997–1999)
Lecture on HIV and AIDS.; Guest speaker at Our Lady of the Sacred Heart School. Presentation to the eighth grade class, topic “HIV and AIDS”.; Guest Lecturer (1997)
Push-Excel Career Awareness Day; Guest speaker for Push-Excel Career Awareness Day at the Academic Challenge Center, Buffalo, New York.; Guest Lecturer (1993)
Monoclonal Center; Director of the Monoclonal Antibody Center.; Director (1992)
Career Day; Guest speaker at Career Day, Attica Middle School, Attica, New York..; Guest Lecturer (1992)
Microbial Pathogenesis; Adhoc reviewer Microbial Pathogenesis.; Ad Hoc Reviewer (1992)
HIV in the community.; Lecture on Viral infections and the Human Immunodeficiency Virus to the Senior Biology Class at Frontier High School, Hamburg, N.Y.; Guest Lecturer (1989)
AIDS risks.; Informational lecture on AIDS to Western New York Association of Hospital Security Guards.; Guest Lecturer (1988)
Clinical Specialties:
Clinical Offices:
Insurance Accepted:
Contact Information
3435 Main Street 143 Biomedical Research Building Buffalo, NY 14214 Phone: (716) 829-2673 Fax: 716-829-3889 Email: aac@buffalo.edu